Mark Messing

Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

Vicky Makker, Matthew H. Taylor, Carol Aghajanian et al. · Journal of Clinical Oncology · 2020 · 522 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

Michael Friedländer, Kenneth C. Hancock, Danny Rischin et al. · Gynecologic Oncology · 2010 · 226 citations

Medicine, Oncology, Pharmacology +15

Carcinoma of the vulva in young women

Mark Messing, DONALD G. GALLUP · Obstetrics and Gynecology · 1995 · 104 citations

Medicine, Gynecology, Oncology +17

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11